Terns Pharmaceuticals, Inc.与翰森制药达成授权协议，根据协议条款，Terns Pharmaceuticals有义务向翰森制药支付一笔100万美元的一次性预付款。此外，协议还规定了基于年度净销售额的分级特许权使用费，费率在0.75%至1.25%之间浮动。
Terns Pharmaceuticals, Inc.与翰森制药达成授权协议，根据协议条款，Terns Pharmaceuticals有义务向翰森制药支付一笔100万美元的一次性预付款。此外，协议还规定了基于年度净销售额的分级特许权使用费，费率在0.75%至1.25%之间浮动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.